481 related articles for article (PubMed ID: 28046055)
1. Role of Interleukin-17A on the Chemotactic Responses to CCL7 in a Murine Allergic Rhinitis Model.
Zhang YL; Han DH; Kim DY; Lee CH; Rhee CS
PLoS One; 2017; 12(1):e0169353. PubMed ID: 28046055
[TBL] [Abstract][Full Text] [Related]
2. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model.
Quan SH; Zhang YL; Han DH; Iwakura Y; Rhee CS
Ann Allergy Asthma Immunol; 2012 May; 108(5):342-50. PubMed ID: 22541406
[TBL] [Abstract][Full Text] [Related]
3. CCR3 gene knockout in bone marrow cells ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing airway inflammatory cell infiltration and Th2 cytokines expression in mice model.
Dai M; Zhu X; Yu J; Yuan J; Zhu Y; Bao Y; Yong X
Int Immunopharmacol; 2022 Mar; 104():108509. PubMed ID: 34998035
[TBL] [Abstract][Full Text] [Related]
4. Effects of lentivirus-mediated CCR3 RNA interference on the function of mast cells of allergic rhinitis in mice.
Wu S; Tang S; Peng H; Jiang Y; Liu Y; Wu Z; Liu Q; Zhu X
Int Immunopharmacol; 2020 Jan; 78():106011. PubMed ID: 31776094
[TBL] [Abstract][Full Text] [Related]
5. Effect of RNA interference therapy on the mice eosinophils CCR3 gene and granule protein in the murine model of allergic rhinitis.
Zhu XH; Liao B; Liu K; Liu YH
Asian Pac J Trop Med; 2014 Mar; 7(3):226-30. PubMed ID: 24507645
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17A-induced inflammation does not influence the development of nasal polyps in murine model.
Hong SL; Zhang YL; Kim SW; Kim DW; Cho SH; Chang YS; Lee CH; Rhee CS
Int Forum Allergy Rhinol; 2015 May; 5(5):363-70. PubMed ID: 25754984
[TBL] [Abstract][Full Text] [Related]
7. The role of hypoxia-inducible factor 1α in allergic rhinitis.
Mo JH; Kim JH; Lim DJ; Kim EH
Am J Rhinol Allergy; 2014; 28(2):e100-6. PubMed ID: 24717944
[TBL] [Abstract][Full Text] [Related]
8. Intralymphatic treatment of flagellin-ovalbumin mixture reduced allergic inflammation in murine model of allergic rhinitis.
Kim EH; Kim JH; Samivel R; Bae JS; Chung YJ; Chung PS; Lee SE; Mo JH
Allergy; 2016 May; 71(5):629-39. PubMed ID: 26752101
[TBL] [Abstract][Full Text] [Related]
9. Antiallergic effect of gami-hyunggyeyeongyotang on ovalbumin-induced allergic rhinitis in mouse and human mast cells.
Im YS; Lee B; Kim EY; Min JH; Song DU; Lim JM; Eom JW; Cho HJ; Sohn Y; Jung HS
J Chin Med Assoc; 2016 Apr; 79(4):185-94. PubMed ID: 26852212
[TBL] [Abstract][Full Text] [Related]
10. C‑C chemokine receptor type 3 gene knockout alleviates inflammatory responses in allergic rhinitis model mice by regulating the expression of eosinophil granule proteins and immune factors.
Zhu X; Liu K; Wang J; Peng H; Pan Q; Wu S; Jiang Y; Liu Y
Mol Med Rep; 2018 Oct; 18(4):3780-3790. PubMed ID: 30106146
[TBL] [Abstract][Full Text] [Related]
11. The effects of resiquimod in an ovalbumin-induced allergic rhinitis model.
Qu S; Qin T; Li M; Zhang S; Ye L; Wei J; Fan H; Chen B
Int Immunopharmacol; 2018 Jun; 59():233-242. PubMed ID: 29665497
[TBL] [Abstract][Full Text] [Related]
12. Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1).
Zheng Y; Guo C; Zhang Y; Qi H; Sun Q; Xu E; Zhang Y; Ma D; Wang Y
Int Immunopharmacol; 2011 Dec; 11(12):2188-93. PubMed ID: 22001899
[TBL] [Abstract][Full Text] [Related]
13. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
14. DMBT1 has a protective effect on allergic rhinitis.
Zhao Y; Tao Q; Wu J; Liu H
Biomed Pharmacother; 2020 Jan; 121():109675. PubMed ID: 31810134
[TBL] [Abstract][Full Text] [Related]
15. The effects of montelukast on tissue inflammatory and bone marrow responses in murine experimental allergic rhinitis: interaction with interleukin-5 deficiency.
Roa J; Morikawa H; Crawford L; Baatjes A; Duong M; Denburg JA
Immunology; 2007 Nov; 122(3):438-44. PubMed ID: 17627772
[TBL] [Abstract][Full Text] [Related]
16. Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis.
Piao CH; Song CH; Lee EJ; Chai OH
Chem Biol Interact; 2020 Jan; 315():108874. PubMed ID: 31669322
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of murine experimental allergic rhinitis: a study of local and systemic consequences of IL-5 deficiency.
Saito H; Matsumoto K; Denburg AE; Crawford L; Ellis R; Inman MD; Sehmi R; Takatsu K; Matthaei KI; Denburg JA
J Immunol; 2002 Mar; 168(6):3017-23. PubMed ID: 11884474
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils.
Fu CH; Tsai WC; Lee TJ; Huang CC; Chang PH; Su Pang JH
PLoS One; 2016; 11(6):e0157186. PubMed ID: 27275740
[TBL] [Abstract][Full Text] [Related]
19. CCR3 gene knockout inhibits proliferation, differentiation, and migration of eosinophils in allergic rhinitis model mice.
Zhang Y; Wang M; Liu Z; Zhu X; Huang Q; Wang J; Liu Y
Mol Immunol; 2023 Oct; 162():1-10. PubMed ID: 37611377
[TBL] [Abstract][Full Text] [Related]
20. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis.
Han DM; Zhou B; Wang T; Wang XD; Fan EZ
Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]